Physician

Shawn K Puri, M.D.

According to 2025 Medicare claims, Shawn Puri, M.D. (NPI: 1598056293) practices pain management in the Killeen-Temple, TX market, with the plurality of this provider's patient population coming from Bell, TX. This provider's primary affiliated billing organization is INTEGRATED PAIN ASSOCIATES PLLC (NPI: 1689800419; TIN: 900491630) and primary practice location at 76542-3340.

Puri's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 511 traditional Medicare patients, billed 3,190 HCPCS/CPT codes, and received $170,930 in Medicare payments. The top billing code was G0482 (Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms). Part D data shows 2,575 prescription claims across 517 beneficiaries totaling $117,243 in drug costs, led by Belbuca (Buprenorphine Hcl). 2019 DME data shows 15 claims. Open Payments data shows 76 records totaling $2,836. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $102,455 to $170,930. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	314	1,160	$102,455
2017	502	3,154	$290,041
2018	604	3,480	$309,411
2019	816	7,667	$548,095
2020	724	6,603	$428,216
2021	688	6,270	$444,585
2022	523	3,116	$248,909
2023	174	1,128	$119,172
2024	511	3,190	$170,930

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	19	38	$5,049
2016	287	920	$100,947
2017	533	3,110	$328,841
2018	537	2,636	$285,358
2019	505	2,524	$290,572
2020	403	1,801	$220,277
2021	478	1,774	$170,065
2022	459	1,862	$174,071
2023	319	2,328	$133,350
2024	517	2,575	$117,243

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	17	17	$12,820
2018	N/R	N/R	N/R
2019	15	15	$11,385
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0482	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms	59	60	$195
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	62	62	$117
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	379	649	$92
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	111	146	$65
80307	Testing for presence of drug, by chemistry analyzers	190	204	$60

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Belbuca	Buprenorphine Hcl	61	1,800	$44,755
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	783	22,230	$17,947
Xtampza Er	Oxycodone Myristate	22	660	$9,392
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	246	6,591	$6,125
Linzess	Linaclotide	11	330	$5,319

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	76	$2,836	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Shawn K. Puri, M.D.?

Tedicare shows public-source Medicare data for Shawn K. Puri, M.D. (NPI 1598056293), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Shawn K. Puri, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Shawn K. Puri, M.D.?

Shawn K. Puri, M.D. is linked to INTEGRATED PAIN ASSOCIATES PLLC (billing NPI 1689800419) in the available physician profile data.

Does Shawn K. Puri, M.D. have Open Payments data?

Shawn K. Puri, M.D. has 76 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.